Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 2nd Quarter - Report (No Activity)

AGIOS PHARMACEUTICALS INC.

via TIBER CREEK GROUP

2nd Quarter (Apr 1 - June 30) · 2023Posted Jul 14, 2023Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: AGIOS PHARMACEUTICALS INC.
Description: Pharmaceutical company.
Location: Massachusetts · United States of America

Registrant

Firm: TIBER CREEK GROUP
Description: Government Relations.
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

AGIOS PHARMACEUTICALS INC. — Lobbying — Receipts Report